UBS analyst Alex Ye upgrades FinVolution Gr (NYSE:FINV) from Neutral to Buy.
The Special Committee Of The Board Of Directors Of Liminal Biosciences Retains An Independent Financial Advisor In Response To Unsolicited Non-Binding Transaction Proposal
Liminal BioSciences Inc. (NASDAQ:LMNL) ("Liminal BioSciences" or the "Company"), re-confirms that the board of directors of the Company has already established a special committee of the